This information
collection is approved for use until November 30,1991 OMB
understands that the current system has been in use for many years
and during this time FDA's duplicative testing has uncovered few
problems. There are products FDA continues to test which have never
had any problems thorughout decades of testing. The insulin market
also includes only two manufacturers, and historically has been
occupied by less than a handful of firms. For these reasons, FDA
must consider the following for its next submission: FDA will seek
a legal determination of 1) its need to continue duplicative batch
testing, 2) any prohibition on reliance solely on manufacturers
data as a basis for certifying batches, and 3) what decisions FDA
can make about a pending certification request for a product based
on problems discovered in previously certified batches of the same
product. FDA will also present its evaluation of alternatives to
the current testing system, including 1) elimination of testing and
reliance on the NDA approval process and post-marketing
surveillance and 2) elimination of testing for products available
for decades for which no problems has ever been detected.
Inventory as of this Action
Requested
Previously Approved
11/30/1991
11/30/1991
440
0
0
550
0
0
0
0
0
ANALYTICAL DATA PREREQUISITE FOR BATCH
CERTIFICATION WITHOUT WHICH THE BATCH CANNOT LEGALLY BE
DISTRIBUTED. PROGRAM IS MANDATED BY STATUTE AND IS SELF-SUPPORTING
THROUGH FEES.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.